BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND TG, Thyroglobulin AND Prognosis
455 results:

  • 1. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
    Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
    BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
    Zhang H; Tian L; Wang X; Shi X
    Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
    Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
    He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
    Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Warthin-like variant of papillary thyroid carcinoma with lymph node metastases: a case report and review of the literature.
    Hryshchyshyn A; Bahrii A; Botsun P; Chuba V
    J Med Case Rep; 2024 Jan; 18(1):17. PubMed ID: 38221623
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
    Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
    Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk factors for parapharyngeal and retropharyngeal metastases in papillary thyroid cancer: a matched case-control study.
    Liu D; Nie X; Yu Q; Shang J
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1531-1539. PubMed ID: 38117306
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Prognostic Power of Preablation Stimulated thyroglobulin in Children With Differentiated thyroid cancer.
    Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR
    Endocr Pract; 2024 Mar; 30(3):209-217. PubMed ID: 38092290
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of Vitamin D3 levels and dietary management in patients with papillary thyroid cancer.
    Koljević-Marković AV; Ristić-Medić DK
    Hell J Nucl Med; 2023; 26(3):194-200. PubMed ID: 38085835
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study.
    Barreto L; Ferreira DCG; Corrente JE; Soares CSP; Oliveira CC; Terra SA; Moriguchi SM; Koga KH; Tagliarini JV; da Silva Mazeto GMF
    Hormones (Athens); 2024 Mar; 23(1):97-106. PubMed ID: 38015413
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction.
    Yang Y; Liao C; Yang Q; Li Y; Tang Y; Xu B
    World J Surg Oncol; 2023 Nov; 21(1):367. PubMed ID: 38007446
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
    Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
    Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
    Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
    Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
    Zhu M; Li J; Zheng WH; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
    [No Abstract]    [Full Text] [Related]  

  • 17. Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism.
    Kızılgül M; Bayır Ö; Uçan B; Akhanlı P; Düğer H; Sencar ME; Kertmen H; Yılmazer D; Yazılıtaş D; Saylam G; Korkmaz MH; Çakal E
    Einstein (Sao Paulo); 2023; 21():eRC0229. PubMed ID: 37493833
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma.
    Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakashima R; Nakamura K; Mizowaki T
    Sci Rep; 2023 Jul; 13(1):10795. PubMed ID: 37402838
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
    Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Male Sex Is Not a Risk Factor for prognosis in Postoperative thyroid cancer Patients: A Propensity Score Matching Study.
    Zhou Y; Wang Y; Zhang Z; Yin X; Liu J; Zheng W
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3330-3337. PubMed ID: 37267432
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 23.